Towards the mechanism and comparative effect of diphenyl diselenide, diphenyl ditelluride and ebselen under various pathophysiological conditions in rat's kidney preparation

Chemico-Biological Interactions

Volumn 182, Issue 1, 2009, Pages 52-58

  Hassan, Waseem ^a   Ibrahim, Mohammad ^a   Rocha, Joao Batista Teixeira ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Diphenyl diselenide; Diphenyl ditelluride and ebselen; Lipid peroxidation; pH

Indexed keywords

ANTIOXIDANT; CHELATING AGENT; DEFEROXAMINE; DIPHENYL DISELENIDE; DIPHENYL DITELLURIDE; EBSELEN; IRON; LIPID; UNCLASSIFIED DRUG;

ACIDOSIS; ADULT ANIMAL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; KIDNEY HOMOGENATE; LIPID PEROXIDATION; MALE; NONHUMAN; PH; RAT;

RATTUS;

EID: 84984533389     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.06.023     Document Type: Article

References (48)

1. McCord J.M. Oxidative stress related diseases-overview. In: Cutler R.G., and Rodriguez H. (Eds). Critical Reviews of Oxidative Stress and Ageing (2003), World Scientific Publishing, Singapore 883-895
2. Halliwell B. Am. J. Med. 91 (1991) S14-S22
3. Sayre L.M., Perry G., and Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3 (1999) 220-225
4. Jacob C., Giles G.I., Giles N.M., and Sies H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. 42 (2003) 4258-4742
5. Giles N.M., Giles G.I., Collins C.A., Holt K., Fry F.H., Lowden P.A.S., Gutowski N.J., and Jacob C. Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapy. Chem. Commun. (2003) 2030-2031
6. Giles N.M., Giles G.I., Gutowski N., Holley J., and Jacob C. Targeting oxidative stress related diseases: organochalcogen catalysts as redox sensitizers. Biochem. Pharmacol. 66 (2003) 2021-2028
7. Mugesh G., Panda A., Singh H.B., Punekar N.S., and Butcher R.J. Antioxidant activity of diaryl diselenides: a mechanistic study. J. Am. Chem. Soc. 123 (2001) 839-850
8. Nogueira C.W., Zeni G., and Rocha J.B.T. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. 104 (2004) 6255-6285
9. Ren X., Xue Y., Zhang K., Liu J., Luo G., Zheng J., Mu Y., and Shen J. A novel dicyclodextrinyl ditelluride compound with antioxidant activity. FEBS Lett. 507 (2001) 377-380
10. Wieslander E., Engman L., Svensjo E., Erlansson M., Johansson U., Linden M., Andersson C.M., and Brattsand R. Antioxidative properties of organotellurium compounds in cell system. Biochem. Pharmacol. 55 (1998) 573-584
11. Engman L., Stern D., Cotgreave I., and Andersson C.M. Thiol peroxidase activity of diaryl ditellurides as determined by a 1H NMR method. J. Am. Chem. Soc. 114 (1992) 9737-9743 (two times)
12. Briviba K., Tamler R., Klotz L.O., Engman L., Cotgreave I.A., and Sies H. Protection against organotellurium compounds against peroxy nitrite mediated oxidation and nitration reactions. Biochem. Pharmacol. 55 (1998) 817-823
13. Kanski J., Drake J., Aksenova M., Engman L., and Butterfield D.A. Antioxidant activity of the organotellurium compound 3-[4-(N,N-dimethylamino) benzenetellurenyl] propanesulfonic acid against oxidative stress in synaptossomal membrane systems and neuronal cultures. Brain Res. 911 (2001) 12-21
14. Jacob C., Arteel G.E., Kanda T., Engman L., and Sies H. Water soluble organotellurium compounds: catalytic protection against peroxynitrite and release of zinc from metallothionein. Chem. Res. Toxicol. 13 (2000) 3-9
15. Andersson C.M., Hallberg A., Brattsand R., Cotgrave I.A., Engman L., and Persson J. Glutathione peroxidase-like activity of diaryl tellurides. Bioorg. Med. Chem. Lett. 3 (1993) 2553-2558
16. Rao A.S., Freemerman A.J., Jarvis W.D., Chelliah J., Bear H.D., Mikkelsen R., and Grant S. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell arrest, and modulation of drug-induced apoptosis in human myeloid leukemia in cells. Leukemia 10 (1996) 1150-1158
17. Cunha L.O.R., Urano M.E., Chagas J.R., Almeida P.C., Bincoletto C., Tersariol I.L.S., and Comasseto J.V. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium (IV) compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem. Lett. 15 (2005) 755-760
18. Engman L., Kanda T., Gallegos A., Williams R., and Powis G. Watersoluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Anti-Cancer Drug Des. 15 (2000) 323-330
19. Paulmier C. Selenium Reagents and Intermediates in Organic Synthesis (1986), Pergamon Press, New York p. 463
20. Petragnani N. Tellurium in Organic Synthesis (1994), Academic Press, San Diego p. 248
21. Engman L., Persson J., and Tilstam U. Pummerer-like reaction of selenium(IV)-dichlorides. Synthesis of α-chloro α-phenylselenenylketones and α, α-dichloro-α-phenylselenenylketones. Tetrahedron. Lett. 30 (1989) 2665-2668
22. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
23. Robson L.P., Daniel H.R., Márcio W.P., Braga A.L., Zeni G., Nogueira C.W., and Rocha J.B.T. Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: effect of diphenyl diselenide and diphenyl ditelluride. Chem. Biol. Interact. 165 (2007) 87-98
24. Schafer F.Q., and Buettner G.R. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic. Biol. Med. 28 (2000) 1175-1181
25. Nyberg K., Johansson U., Rundquist I., and Camner P. Estimation of pH in individual alveolar macrophage phagolysosomes. Exp. Lung Res. 15 (1989) 499-510
26. Eaton J.W., and Qian M. Molecular bases of cellular iron toxicity. Free Radic. Biol. Med. 32 (2002) 833-840
27. Garner B., Roberg K., and Brunk U.T. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Radic. Res. 29 (1998) 103-114
28. Wike-Hooley J.L., Haveman J., and Reinhold H.S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2 (1984) 343-366
29. Cohen J.S., Motiei M., Carmi S., Shiperto D., Yefet O., and Ringel I. Determination of intracellular pH and compartmentation using diffusion-weighted NMR spectroscopy with pH-sensitive indicators. Magn. Reson. Med. 51 (2004) 900-903
30. Ohkuma S., and Poole B. Fluorescence probe measurement of intralysosomal pH in living cells and perturbation of pH by various agents. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 3327-3331
31. Mabrouk A.F., and Dugan L.R.J.R. A kinetic study of the autoxidation of methyl linoleate and linoleic acid emulsions in the presence of sodium chloride. J. Am. Oil Chem. Soc. 37 (1960) 486-490
32. Wills E.D. Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation of unsaturated fatty acids. Biochim. Biophys. Acta 98 (1965) 238-251
33. Bralet S.L., and Bouvier C. Effect of acidosis and anoxia on iron delocalization from brain homogenates. Biochem. Biophys. 43 (1992) 979-983
34. Bralet J., Bouvier C., Schreiber L., and Boquillon M. Effect of acidosis on lipid peroxidation in brain slices. Brain Res. 539 (1991) 175-177
35. Zimmerman J.J., and Lewandoski J.R. In vitro phosphatidylcholine peroxidation mediated by activated human neutrophils. Circ. Shock 34 (1991) 231-239
36. Misi{dotless}k V., Svajdlenka E., Fili{dotless}pek J., Gergel D., and Ondrias K. Inhibition of lipid peroxidation of lecithin liposomes kept in a pH stat system near neutral pH. Free Radic. Res. Commun. 15 (1991) 159-165
37. Corliss G.A., and Dugan L.R.J.R. Phospholipid oxidation in emulsions. Lipids 5 (1970) 846-853
38. Welch S.A. Comparison of the structure and properties of serum transferrin from 17 animal species. Comp. Biochem. Physiol. 97B (1990) 417-427
39. Balla G., Vercellotti G.M., Eaton J.W., and Jacob H.S. Iron loading of endothelial cells augments oxidant damage. J. Lab. Clin. Med. 116 (1990) 546-554
40. Liochev S.I., and Fridovich I. The Haber-Weiss cycle-70 years later: an alternative view. Redox Rep. 7 (2002) 55-57 (author reply 59-60)
41. Hassan W., Ibrahim M., Nogueira C.W., Braga A.L., Deobald A.M., Zai I.M., and Rocha J.B.T. Influence of pH on the reactivity of diphenyl ditelluride with thiols and anti-oxidant potential in rat brain. Chem. Biol. Interact. 180 (2009) 47-53
42. Hassan W., Ibrahim M., Deobald A.M., Braga A.L., Nogueira C.W., and Rocha J.B.T. pH dependent Fe (II) pathophysiology and protective effect of an Organoselenium compound. FEBS Lett. 583 (2009) 1011-1016
43. Maiorino M., Roveri A., Coassin M., and Ursini F. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem. Pharmacol. 37 (1998) 2267
44. Bors W., Michel C., and Sara M. On the nature of biochemically generated hydroxyl radicals. Eur. J. Biochem. 95 (1979) 621-627
45. Bucher J.R., Tien M., and Aust S.D. The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron. Biochem. Biophys. Res. Commun. 111 (1983) 777-784
46. Pederson T.C., Buege J.A., and Aust S.D. Microsomal electron transport. The role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J. Biol. Chem. 248 (1973) 7134-7141
47. Engman L., Stern D., and Pelcman M. Thiol peroxidase activity of diorganyl tellurides. J. Org. Chem. 59 (1994) 1973
48. Andersson C., Brattsand R., Hallberg A., Engman L., Persson J., Moldeus P., and Cotgreave I. Diaryl tellurides as inhibitors of lipid peroxidation in biological and chemical systems. Free Radic. Res. 20 (1994) 401-404